Chrome Plugin Live! Redefine the way you read FinTwit š Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ELAB
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.23
N/A
-0.08
vsĀ -0.05
Q4.23
N/A
-111.97
vsĀ -0.07
Q1.24
N/A
-111.97
vsĀ -0.06
Q2.24
N/A
-111.97
vsĀ -0.08
Q3.24
N/A
-97.97
vsĀ -0.08
Q4.24
+100%
NA
vsĀ -111.97
Q1.25
N/A
NA
vsĀ -111.97
Sales Growth
YoY
Current
Estimates
Q3.23
+28%
554.7KĀ vsĀ 432.1K
Q4.23
+403%
698.6KĀ vsĀ 138.9K
Q1.24
+330%
614.6KĀ vsĀ 142.8K
Q2.24
+91%
605.5KĀ vsĀ 316.5K
Q3.24
-5%
527.5KĀ vsĀ 554.7K
Q4.24
-350%
-1747570.00Ā vsĀ 698.6K
Q1.25
-100%
NAĀ vsĀ 614.6K
Return on Equity
QoQ
Q2.23
-1902%
-19.02
vsĀ NA
Q3.23
+478%
4.78
vsĀ -19.02
Q4.23
-30%
-0.30
vsĀ 4.78
Q1.24
-56%
-0.56
vsĀ -0.30
Q2.24
-54%
-0.54
vsĀ -0.56
Q3.24
-18%
-0.18
vsĀ -0.54
Q4.24
-29%
-0.29
vsĀ -0.18
Q1.25
NA
NA
vsĀ -0.29
Institutionnal Ownership
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
0.07Ā ( 2.92%)
Pre-market 2.45$
-0.02 (-0.81%)
Relative Strenght
Volume Buzz
-87%
Earning Acce
No
Dist 52w H.
100%Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
globenewswire.com
8 hours ago
globenewswire.com
16 hours ago
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How ELAB compares to sector?
ELAB
0x
